Prostate cancer
AEMD 2022-06
AETHLON -- Safety, Feasibility and Dose-Finding Study of Aethlon Hemopurifier in Patients with Solid Tumors who have stable or progressive disease while on a treatment that includes Pembrolizumab or Nivolumab
Trial overview
Clinical Area
Medical Oncology
Disease
Basket
Disease site
Basket
Study Phase
I
Trial Identifiers
Registration number: ACTRN12624000732583
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=387513&isReview=true
Principal Investigator(s)
··
··